Arrowstreet Capital’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $26.6M | Buy |
+122,181
| New | +$27.1M | 0.01% | 673 |
|
|
2025
Q4 | – | Sell |
-184,689
| Closed | -$42.8M | – | 1809 |
|
|
2025
Q3 | $42.8M | Sell |
184,689
-132,024
| -42% | -$26.9M | 0.03% | 506 |
|
|
2025
Q2 | $58.8M | Sell |
316,713
-45,182
| -12% | -$8.4M | 0.04% | 380 |
|
|
2025
Q1 | $75.8M | Sell |
361,895
-283,074
| -44% | -$55M | 0.06% | 281 |
|
|
2024
Q4 | $115M | Buy |
644,969
+185,820
| +40% | +$34.2M | 0.09% | 199 |
|
|
2024
Q3 | $90.7M | Buy |
459,149
+276,075
| +151% | +$51.5M | 0.08% | 225 |
|
|
2024
Q2 | $31.4M | Buy |
183,074
+97,394
| +114% | +$16.1M | 0.03% | 381 |
|
|
2024
Q1 | $15.6M | Sell |
85,680
-263,428
| -75% | -$45.4M | 0.01% | 566 |
|
|
2023
Q4 | $54.1M | Buy |
349,108
+277,358
| +387% | +$40.4M | 0.06% | 255 |
|
|
2023
Q3 | $10.7M | Buy |
71,750
+4,612
| +7% | +$677K | 0.01% | 506 |
|
|
2023
Q2 | $9.05M | Buy |
67,138
+51,202
| +321% | +$7.51M | 0.01% | 528 |
|
|
2023
Q1 | $2.54M | Buy |
+15,936
| New | +$2.44M | ﹤0.01% | 858 |
|
|
2022
Q4 | – | Sell |
-3,215,907
| Closed | -$432M | – | 1306 |
|
|
2022
Q3 | $432M | Sell |
3,215,907
-1,055,102
| -25% | -$151M | 0.64% | 38 |
|
|
2022
Q2 | $654M | Sell |
4,271,009
-381,113
| -8% | -$58.2M | 0.93% | 20 |
|
|
2022
Q1 | $754M | Buy |
4,652,122
+3,768,579
| +427% | +$547M | 0.94% | 18 |
|
|
2021
Q4 | $120M | Sell |
883,543
-1,029,449
| -54% | -$122M | 0.15% | 168 |
|
|
2021
Q3 | $206M | Buy |
1,912,992
+1,804,393
| +1,662% | +$206M | 0.26% | 89 |
|
|
2021
Q2 | $12.2M | Sell |
108,599
-21,501
| -17% | -$2.42M | 0.02% | 776 |
|
|
2021
Q1 | $14.1M | Buy |
+130,100
| New | +$13.9M | 0.02% | 729 |
|
|
2020
Q4 | – | Sell |
-253,000
| Closed | -$22.2M | – | 2248 |
|
|
2020
Q3 | $22.2M | Buy |
253,000
+220,000
| +667% | +$20.7M | 0.04% | 512 |
|
|
2020
Q2 | $3.24M | Sell |
33,000
-5,722,097
| -99% | -$504M | 0.01% | 1244 |
|
|
2020
Q1 | $438M | Buy |
5,755,097
+626,639
| +12% | +$53.4M | 1.23% | 10 |
|
|
2019
Q4 | $454M | Sell |
5,128,458
-2,335,648
| -31% | -$194M | 1.06% | 9 |
|
|
2019
Q3 | $565M | Buy |
7,464,106
+65,172
| +0.9% | +$4.47M | 1.32% | 8 |
|
|
2019
Q2 | $538M | Buy |
7,398,934
+483,145
| +7% | +$38M | 1.2% | 9 |
|
|
2019
Q1 | $557M | Sell |
6,915,789
-228,540
| -3% | -$18.7M | 1.32% | 8 |
|
|
2018
Q4 | $659M | Sell |
7,144,329
-1,918,859
| -21% | -$169M | 1.73% | 6 |
|
|
2018
Q3 | $857M | Sell |
9,063,188
-2,917,106
| -24% | -$277M | 1.94% | 7 |
|
|
2018
Q2 | $1.11B | Buy |
11,980,294
+3,763,730
| +46% | +$368M | 2.72% | 1 |
|
|
2018
Q1 | $778M | Buy |
8,216,564
+6,133,793
| +295% | +$674M | 1.78% | 5 |
|
|
2017
Q4 | $201M | Sell |
2,082,771
-786,282
| -27% | -$74.1M | 0.48% | 51 |
|
|
2017
Q3 | $255M | Buy |
2,869,053
+2,448,090
| +582% | +$186M | 0.68% | 42 |
|
|
2017
Q2 | $30.5M | Buy |
420,963
+41,263
| +11% | +$2.77M | 0.09% | 201 |
|
|
2017
Q1 | $24.7M | Buy |
+379,700
| New | +$23.9M | 0.09% | 229 |
|
|
2016
Q4 | – | Sell |
-250,786
| Closed | -$15.8M | – | 1564 |
|
|
2016
Q3 | $15.8M | Buy |
250,786
+242,486
| +2,922% | +$15.7M | 0.05% | 347 |
|
|
2016
Q2 | $514K | Sell |
8,300
-459,100
| -98% | -$28M | ﹤0.01% | 1137 |
|
|
2016
Q1 | $26.7M | Buy |
467,400
+356,000
| +320% | +$19.8M | 0.11% | 194 |
|
|
2015
Q4 | $6.6M | Buy |
+111,400
| New | +$6.42M | 0.03% | 470 |
|
|
2015
Q3 | – | Sell |
-129,481
| Closed | -$8.7M | – | 1325 |
|
|
2015
Q2 | $8.7M | Sell |
129,481
-297,377
| -70% | -$19.4M | 0.05% | 299 |
|
|
2015
Q1 | $25M | Buy |
+426,858
| New | +$25.8M | 0.15% | 152 |
|
|
2014
Q4 | – | Sell |
-2,162,776
| Closed | -$125M | – | 1210 |
|
|
2014
Q3 | $125M | Sell |
2,162,776
-2,566,709
| -54% | -$142M | 0.67% | 30 |
|
|
2014
Q2 | $267M | Sell |
4,729,485
-391,497
| -8% | -$20.5M | 1.37% | 11 |
|
|
2014
Q1 | $263M | Buy |
5,120,982
+1,418,020
| +38% | +$71.7M | 1.59% | 5 |
|
|
2013
Q4 | $196M | Buy |
3,702,962
+35,887
| +1% | +$1.76M | 1.06% | 12 |
|
|
2013
Q3 | $164M | Sell |
3,667,075
-1,159,690
| -24% | -$51.4M | 1.04% | 18 |
|
|
2013
Q2 | $200M | Buy |
+4,826,765
| New | +$211M | 1.49% | 10 |
|
Other funds holding ABBV
VCM
VPM
Arrowstreet Capital's ABBV Position: Q1 2026 in Review
Arrowstreet Capital opened a new position in AbbVie (ABBV) in Q1 2026: 122,181 shares worth $26.6M. The stake represents 0.01% of the portfolio and ranks #673 among its holdings. This is a return to the name: Arrowstreet Capital previously reported a position in ABBV as recently as Q3 2025.
Arrowstreet Capital first reported a position in ABBV in Q2 2013 and has held it in 46 quarters since. The position peaked at $1.11B in Q2 2018. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Arrowstreet Capital held 122,181 shares of AbbVie worth $26.6M as of Q1 2026.
- AbbVie was a new Arrowstreet Capital position in Q1 2026.
- AbbVie made up 0.01% of Arrowstreet Capital's portfolio in Q1 2026, its #673 holding.
- Arrowstreet Capital first reported a position in AbbVie in Q2 2013 and has held it in 46 quarters since.
- Arrowstreet Capital's AbbVie position peaked at $1.11B in Q2 2018.
- 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Arrowstreet Capital's 13F filing for Q1 2026, filed 14 May 2026.